June 12, 2024
Humira Biosimilar Market to Grow Due to Robust Pipeline of New Products
The Humira biosimilar market has shown significant growth in recent years. Humira, developed by AbbVie Inc., is a monoclonal antibody used for the treatment of several inflammatory diseases like rheumatoid arthritis, psoriasis, ulcerative colitis and Crohn’s disease. Being an injectable drug, Humira has gained immense popularity among patients and healthcare professionals as it helps reduce…
nishantcmi